Yearly Archives: 2003


Imatinib Discontinuation Can Result in “PET Flare”

Anecdotal evidence is accumulating that a particularly ominous sign on FDG-PET scans is associated with discontinuation of imatinib therapy in GIST patients. Termed a “PET flare,” it was observed by the Dana-Farber team of the [...]

By |2019-12-24T10:24:53-05:00March 5th, 2003|News, Research|

Managing Progression: Dr. Charles D. Blanke Discusses Gleevec Resistance

Managing Progression - Clinical Management of GIST Helsinki and Barcelona 2003-Conference Highlights Charles D. Blanke, M.D., director of gastrointestinal oncology at Oregon Health and Science University (OHSU), Portland, Oregon, USA, discussed the treatment of [...]

By |2019-12-24T10:25:40-05:00March 5th, 2003|Research|
Go to Top